Market Overview
China represents one of the largest respiratory device markets within the Asia Pacific region, with a 2025 valuation of approximately $1.44 billion. The market spans a broad portfolio of products including therapeutic devices, consumables, and diagnostic equipment. Demand is driven by the country's high burden of respiratory diseases combined with improving healthcare infrastructure.
- •Market valued at $1.44 billion in 2025 with 7.9% projected annual growth
- •Product categories include therapeutic devices, consumables, and diagnostic equipment
- •High prevalence of respiratory disease conditions in the general population
Growth Drivers
An aging population in China is significantly expanding the pool of patients requiring respiratory care for age-related conditions like COPD. Rising levels of air pollution in major urban centers have increased the incidence of respiratory ailments, driving greater demand for therapeutic and diagnostic devices. Government initiatives to expand healthcare access and insurance coverage are making respiratory treatments more accessible to a broader segment of the population.
- •Growing elderly demographic increasing demand for chronic respiratory disease management
- •Air pollution levels contributing to higher incidence of asthma, COPD, and related conditions
- •Government healthcare reforms improving insurance coverage and device accessibility
- •Expanding adoption of home-based respiratory care reducing hospitalization costs
Segmentation and Regional Analysis
The market is segmented by product type, with therapeutic devices including continuous positive airway pressure (CPAP) devices, oxygen concentrators, and ventilators representing the largest segment. By application, the market serves sleep apnea, COPD, asthma, and infectious respiratory diseases. End-users are primarily hospitals, specialty clinics, and an increasingly significant home care sector.
- •Therapeutic devices (PAP devices, oxygen concentrators, ventilators) dominate the product segment
- •Sleep apnea and COPD represent the largest indication categories
- •Home care settings are the fastest-growing end-user segment as care shifts from hospitals
- •Eastern China's major urban centers account for a substantial share of regional demand
Trends and Outlook
What are the recent trends and outlook?
Digital respiratory devices incorporating connected sensors and remote patient monitoring capabilities are gaining traction in the Chinese market. The shift toward home-based care is accelerating demand for portable and user-friendly respiratory equipment. Over the forecast period, these technological and care-model trends are expected to sustain the market's growth trajectory.
- •Connected respiratory devices with remote monitoring capabilities expanding rapidly
- •Home care adoption continuing to grow as healthcare delivery models evolve
- •Smart device innovation driving next-generation product development
- •Asia-Pacific region positioned for above-average growth through 2030
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.